A citation-based method for searching scientific literature

Margaret M Redfield, Horng H Chen, Barry A Borlaug, Marc J Semigran, Kerry L Lee, Gregory Lewis, Martin M LeWinter, Jean L Rouleau, David A Bull, Douglas L Mann, Anita Deswal, Lynne W Stevenson, Michael M Givertz, Elizabeth O Ofili, Christopher M O'Connor, G Michael Felker, Steven R Goldsmith, Bradley A Bart, Steven E McNulty, Jenny C Ibarra, Grace Lin, Jae K Oh, Manesh R Patel, Raymond J Kim, Russell P Tracy, Eric J Velazquez, Kevin J Anstrom, Adrian F Hernandez, Alice M Mascette, Eugene Braunwald. JAMA 2013
Times Cited: 784







List of co-cited articles
2318 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.
Scott D Solomon, John J V McMurray, Inder S Anand, Junbo Ge, Carolyn S P Lam, Aldo P Maggioni, Felipe Martinez, Milton Packer, Marc A Pfeffer, Burkert Pieske,[...]. N Engl J Med 2019
724
34

Spironolactone for heart failure with preserved ejection fraction.
Bertram Pitt, Marc A Pfeffer, Susan F Assmann, Robin Boineau, Inder S Anand, Brian Claggett, Nadine Clausell, Akshay S Desai, Rafael Diaz, Jerome L Fleg,[...]. N Engl J Med 2014
31

Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction.
Margaret M Redfield, Kevin J Anstrom, James A Levine, Gabe A Koepp, Barry A Borlaug, Horng H Chen, Martin M LeWinter, Susan M Joseph, Sanjiv J Shah, Marc J Semigran,[...]. N Engl J Med 2015
313
26

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.
Salim Yusuf, Marc A Pfeffer, Karl Swedberg, Christopher B Granger, Peter Held, John J V McMurray, Eric L Michelson, Bertil Olofsson, Jan Ostergren. Lancet 2003
24

Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction: The INDIE-HFpEF Randomized Clinical Trial.
Barry A Borlaug, Kevin J Anstrom, Gregory D Lewis, Sanjiv J Shah, James A Levine, Gabe A Koepp, Michael M Givertz, G Michael Felker, Martin M LeWinter, Douglas L Mann,[...]. JAMA 2018
120
23

Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study.
Burkert Pieske, Aldo P Maggioni, Carolyn S P Lam, Elisabeth Pieske-Kraigher, Gerasimos Filippatos, Javed Butler, Piotr Ponikowski, Sanjiv J Shah, Scott D Solomon, Andrea-Viviana Scalise,[...]. Eur Heart J 2017
186
22


Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.
Paul W Armstrong, Burkert Pieske, Kevin J Anstrom, Justin Ezekowitz, Adrian F Hernandez, Javed Butler, Carolyn S P Lam, Piotr Ponikowski, Adriaan A Voors, Gang Jia,[...]. N Engl J Med 2020
320
20

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur Heart J 2016
19

Irbesartan in patients with heart failure and preserved ejection fraction.
Barry M Massie, Peter E Carson, John J McMurray, Michel Komajda, Robert McKelvie, Michael R Zile, Susan Anderson, Mark Donovan, Erik Iverson, Christoph Staiger,[...]. N Engl J Med 2008
19

Effects of sildenafil on invasive haemodynamics and exercise capacity in heart failure patients with preserved ejection fraction and pulmonary hypertension: a randomized controlled trial.
Elke S Hoendermis, Licette C Y Liu, Yoran M Hummel, Peter van der Meer, Rudolf A de Boer, Rolf M F Berger, Dirk J van Veldhuisen, Adriaan A Voors. Eur Heart J 2015
199
19

Effect of Vericiguat vs Placebo on Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The VITALITY-HFpEF Randomized Clinical Trial.
Paul W Armstrong, Carolyn S P Lam, Kevin J Anstrom, Justin Ezekowitz, Adrian F Hernandez, Christopher M O'Connor, Burkert Pieske, Piotr Ponikowski, Sanjiv J Shah, Scott D Solomon,[...]. JAMA 2020
68
26

Angiotensin-neprilysin inhibition versus enalapril in heart failure.
John J V McMurray, Milton Packer, Akshay S Desai, Jianjian Gong, Martin P Lefkowitz, Adel R Rizkala, Jean L Rouleau, Victor C Shi, Scott D Solomon, Karl Swedberg,[...]. N Engl J Med 2014
18

Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
Masaru Obokata, Yogesh N V Reddy, Sorin V Pislaru, Vojtech Melenovsky, Barry A Borlaug. Circulation 2017
423
17

Trends in prevalence and outcome of heart failure with preserved ejection fraction.
Theophilus E Owan, David O Hodge, Regina M Herges, Steven J Jacobsen, Veronique L Roger, Margaret M Redfield. N Engl J Med 2006
16

Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
John J V McMurray, Scott D Solomon, Silvio E Inzucchi, Lars Køber, Mikhail N Kosiborod, Felipe A Martinez, Piotr Ponikowski, Marc S Sabatine, Inder S Anand, Jan Bělohlávek,[...]. N Engl J Med 2019
16

The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase 2 double-blind randomised controlled trial.
Scott D Solomon, Michael Zile, Burkert Pieske, Adriaan Voors, Amil Shah, Elisabeth Kraigher-Krainer, Victor Shi, Toni Bransford, Madoka Takeuchi, Jianjian Gong,[...]. Lancet 2012
726
15

Nitrosative stress drives heart failure with preserved ejection fraction.
Gabriele G Schiattarella, Francisco Altamirano, Dan Tong, Kristin M French, Elisa Villalobos, Soo Young Kim, Xiang Luo, Nan Jiang, Herman I May, Zhao V Wang,[...]. Nature 2019
231
15

Low myocardial protein kinase G activity in heart failure with preserved ejection fraction.
Loek van Heerebeek, Nazha Hamdani, Inês Falcão-Pires, Adelino F Leite-Moreira, Mark P V Begieneman, Jean G F Bronzwaer, Jolanda van der Velden, Ger J M Stienen, Gerrit J Laarman, Aernout Somsen,[...]. Circulation 2012
299
14

The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
John G F Cleland, Michal Tendera, Jerzy Adamus, Nick Freemantle, Lech Polonski, Jacqueline Taylor. Eur Heart J 2006
918
14

Empagliflozin in Heart Failure with a Preserved Ejection Fraction.
Stefan D Anker, Javed Butler, Gerasimos Filippatos, João P Ferreira, Edimar Bocchi, Michael Böhm, Hans-Peter Brunner-La Rocca, Dong-Ju Choi, Vijay Chopra, Eduardo Chuquiure-Valenzuela,[...]. N Engl J Med 2021
378
14

Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial.
Marc A Pfeffer, Brian Claggett, Susan F Assmann, Robin Boineau, Inder S Anand, Nadine Clausell, Akshay S Desai, Rafael Diaz, Jerome L Fleg, Ivan Gordeev,[...]. Circulation 2015
523
13

Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial.
Frank Edelmann, Rolf Wachter, Albrecht G Schmidt, Elisabeth Kraigher-Krainer, Caterina Colantonio, Wolfram Kamke, André Duvinage, Raoul Stahrenberg, Kathleen Durstewitz, Markus Löffler,[...]. JAMA 2013
463
13

Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction.
Constantijn Franssen, Sophia Chen, Andreas Unger, H Ibrahim Korkmaz, Gilles W De Keulenaer, Carsten Tschöpe, Adelino F Leite-Moreira, René Musters, Hans W M Niessen, Wolfgang A Linke,[...]. JACC Heart Fail 2016
265
13

Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.
Sanjiv J Shah, Dalane W Kitzman, Barry A Borlaug, Loek van Heerebeek, Michael R Zile, David A Kass, Walter J Paulus. Circulation 2016
498
13


Effect of Praliciguat on Peak Rate of Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: The CAPACITY HFpEF Randomized Clinical Trial.
James E Udelson, Gregory D Lewis, Sanjiv J Shah, Michael R Zile, Margaret M Redfield, John Burnett, John Parker, Jelena P Seferovic, Phebe Wilson, Robert S Mittleman,[...]. JAMA 2020
30
43

Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose study.
Diana Bonderman, Ingrid Pretsch, Regina Steringer-Mascherbauer, Pavel Jansa, Stephan Rosenkranz, Caroline Tufaro, Andja Bojic, Carolyn S P Lam, Reiner Frey, Michael Ochan Kilama,[...]. Chest 2014
165
12

Riociguat for patients with pulmonary hypertension caused by systolic left ventricular dysfunction: a phase IIb double-blind, randomized, placebo-controlled, dose-ranging hemodynamic study.
Diana Bonderman, Stefano Ghio, Stephan B Felix, Hossein-Ardeschir Ghofrani, Evangelos Michelakis, Veselin Mitrovic, Ronald J Oudiz, Francis Boateng, Andrea-Viviana Scalise, Lothar Roessig,[...]. Circulation 2013
205
12


Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.
Philip B Adamson, William T Abraham, Robert C Bourge, Maria Rosa Costanzo, Ayesha Hasan, Chethan Yadav, John Henderson, Pam Cowart, Lynne Warner Stevenson. Circ Heart Fail 2014
237
12

Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study.
Carolyn S P Lam, Véronique L Roger, Richard J Rodeheffer, Barry A Borlaug, Felicity T Enders, Margaret M Redfield. J Am Coll Cardiol 2009
690
12

Right heart dysfunction in heart failure with preserved ejection fraction.
Vojtech Melenovsky, Seok-Jae Hwang, Grace Lin, Margaret M Redfield, Barry A Borlaug. Eur Heart J 2014
347
12

A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction.
Yogesh N V Reddy, Rickey E Carter, Masaru Obokata, Margaret M Redfield, Barry A Borlaug. Circulation 2018
319
12

Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction.
Selma F Mohammed, Saad Hussain, Sultan A Mirzoyev, William D Edwards, Joseph J Maleszewski, Margaret M Redfield. Circulation 2015
419
12

How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC).
Burkert Pieske, Carsten Tschöpe, Rudolf A de Boer, Alan G Fraser, Stefan D Anker, Erwan Donal, Frank Edelmann, Michael Fu, Marco Guazzi, Carolyn S P Lam,[...]. Eur Heart J 2019
370
12

Sacubitril/Valsartan Across the Spectrum of Ejection Fraction in Heart Failure.
Scott D Solomon, Muthiah Vaduganathan, Brian L Claggett, Milton Packer, Michael Zile, Karl Swedberg, Jean Rouleau, Marc A Pfeffer, Akshay Desai, Lars H Lund,[...]. Circulation 2020
153
12

Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF.
Sanjiv J Shah, Carolyn S P Lam, Sara Svedlund, Antti Saraste, Camilla Hage, Ru-San Tan, Lauren Beussink-Nelson, Ulrika Ljung Faxén, Maria Lagerström Fermer, Malin A Broberg,[...]. Eur Heart J 2018
195
12

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
12

Epidemiology of heart failure with preserved ejection fraction.
Shannon M Dunlay, Véronique L Roger, Margaret M Redfield. Nat Rev Cardiol 2017
452
11

Heart Failure With Preserved Ejection Fraction In Perspective.
Marc A Pfeffer, Amil M Shah, Barry A Borlaug. Circ Res 2019
232
11

Haemodynamic definitions and updated clinical classification of pulmonary hypertension.
Gérald Simonneau, David Montani, David S Celermajer, Christopher P Denton, Michael A Gatzoulis, Michael Krowka, Paul G Williams, Rogerio Souza. Eur Respir J 2019
11

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.
Piotr Ponikowski, Adriaan A Voors, Stefan D Anker, Héctor Bueno, John G F Cleland, Andrew J S Coats, Volkmar Falk, José Ramón González-Juanatey, Veli-Pekka Harjola, Ewa A Jankowska,[...]. Eur J Heart Fail 2016
11

Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy.
Eiki Takimoto, Hunter C Champion, Manxiang Li, Diego Belardi, Shuxun Ren, E Rene Rodriguez, Djahida Bedja, Kathleen L Gabrielson, Yibin Wang, David A Kass. Nat Med 2005
685
11

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Milton Packer, Stefan D Anker, Javed Butler, Gerasimos Filippatos, Stuart J Pocock, Peter Carson, James Januzzi, Subodh Verma, Hiroyuki Tsutsui, Martina Brueckmann,[...]. N Engl J Med 2020
11

Effect of Caloric Restriction or Aerobic Exercise Training on Peak Oxygen Consumption and Quality of Life in Obese Older Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical Trial.
Dalane W Kitzman, Peter Brubaker, Timothy Morgan, Mark Haykowsky, Gregory Hundley, William E Kraus, Joel Eggebeen, Barbara J Nicklas. JAMA 2016
379
11


Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary.
Sanjiv J Shah, Barry A Borlaug, Dalane W Kitzman, Andrew D McCulloch, Burns C Blaxall, Rajiv Agarwal, Julio A Chirinos, Sheila Collins, Rahul C Deo, Mark T Gladwin,[...]. Circulation 2020
90
11

Clinical Phenogroups in Heart Failure With Preserved Ejection Fraction: Detailed Phenotypes, Prognosis, and Response to Spironolactone.
Jordana B Cohen, Sarah J Schrauben, Lei Zhao, Michael D Basso, Mary Ellen Cvijic, Zhuyin Li, Melissa Yarde, Zhaoqing Wang, Priyanka T Bhattacharya, Diana A Chirinos,[...]. JACC Heart Fail 2020
86
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.